RenalGuard Therapy Gets Breakthrough Device Designation for Prevention of Cardiac Surgery Associated AKI
The FDA granted Breakthrough Device Designation for CardioRenal Systems' RenalGuard Therapy device for the prevention of acute kidney injury.
The FDA granted Breakthrough Device Designation for CardioRenal Systems' RenalGuard Therapy device for the prevention of acute kidney injury.
HeartBeam announced the expansion of its product portfolio pipeline to serve the growing cardiac device wearable technology market.
The U.S. FDA has cleared Eko's Murmur Analysis Software for detecting and characterizing murmurs found in adults and pediatric patients.
The FDA granted Breakthrough Device Designation for CardioRenal Systems' RenalGuard Therapy device for the prevention of acute kidney injury.
Kestra Medical Technologies’ ASSURE WCD system is effective at reducing false-positive shock alarms, according to clinical evaluation results.
Read MorePhysicians accessing GE Healthcare’s cardiac management system that integrates into the EMR, can interpret data in MUSE ECGs from patients.
Read MoreThese ablation catheters were approved to treat the growing prevalence of pediatric Atrioventricular Nodal Reentrant Tachycardia (AVNRT).
Read MoreRoyal Philips has unveiled a full-service, at-home, 12-lead electrocardiogram (ECG) solution for use in decentralized clinical trials.
Read MoreThe preventive maintenance program is designed to help imaging departments offset the costly expenses of owning and operating TEE probes.
Read MoreAbbott has received FDA clearance for a new cardiac mapping platform that is designed to help physicians better treat abnormal heart rhythm.
Read MoreApproximately 70% of out-of-hospital cardiac arrests occur in private homes that don’t have an automated external defibrillator.